Literature DB >> 32584402

Covid-19 in dementia: an insidious pandemic.

Jasper Seth Yao1, Edward Christopher Dee2, Carmelo Milazzo1, Jerry Jurado1, Joseph Alexander Paguio1.   

Abstract

Entities:  

Keywords:  AMS; Covid-19; SARS-COV-2; advanced directives; altered mental status; coronavirus; dementia; nursing home; pandemic

Mesh:

Year:  2020        PMID: 32584402      PMCID: PMC7337638          DOI: 10.1093/ageing/afaa136

Source DB:  PubMed          Journal:  Age Ageing        ISSN: 0002-0729            Impact factor:   10.668


× No keyword cloud information.
Sir, Older age is a key risk factor for worse outcomes in coronavirus disease 2019 (Covid-19) [1]. With a national prevalence of 13.9% among those aged ≥71 [2], a diagnosis of dementia in an already vulnerable population may have implications on the assessment and management of this acute infection. Our study aims to describe the clinical course of hospitalised patients with dementia and Covid-19. Clinical history and characteristics of Covid-19 patients with dementia aPatients with critical disease were those who developed acute respiratory distress syndrome, septic shock or multiorgan failure, or those who required mechanical ventilation or ICU admission. Patients were classified as having severe disease if their oxygen saturation was 93% and below when measured by pulse oximetry or if their respiratory rate was 30 breaths per min or higher without meeting any of the criteria for critical disease. Mild pneumonia was diagnosed in patients with an oxygen saturation on room air of 94% and above when measured by pulse oximetry and a respiratory frequency of less than 30 breaths per min without meeting any of the criteria for severe or critical disease. DNR, do not resuscitate; DNI, do not intubate. We identified 36 consecutive Covid-19 patients with dementia admitted at the Hoboken University Medical Center from 16 March to 11 April 2020. Covid-19 was confirmed in all patients using quantitative real time reverse transcription polymerase chain reaction for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) RNA. The diagnosis of dementia was based on the clinical assessment in the hospital chart or documents provided by the long-term care facility or emergency medical services. Patient demographic and clinical information were extracted, and the data from the first 24 h of admission were used to determine clinical severity based on WHO guidelines [3]. Patients with critical disease were those who developed acute respiratory distress syndrome, septic shock or multiorgan failure, or those who required mechanical ventilation or ICU admission. The median age of the 36 Covid-19 patients with dementia was 84 years (range 59–97), and 22 (61.1%) were female. Eleven (30.6%) patients with dementia presented with critical Covid-19. Thirty-five of the patients (97.2%) were unable to provide a clinical history (Table 1); 26 patients (72.2%) came from a nursing home. The most common chief complaints offered by the historian were shortness of breath (61.1%), altered mental status (16.7%), fever (11.1%) and fall (5.5%).
Table 1

Clinical history and characteristics of Covid-19 patients with dementia

Clinical characteristics of patients with dementia n(%)
Number of patients 36
Age, median (range) 84 (59-97)
Sex
 Male14 (38.9%)
 Female22 (61.1%)
History provided by a relative or nursing home document 35 (97.2%)
Residence 24 (66.7%)
  Nursing home26 (72.2%)
  Home10 (27.8%)
Unknown duration of illness 21 (58.3%)
Clinical severity on admissiona
 Mild8 (22.2%)
 Severe17 (47.2%)
 Critical11 (30.6%)
Chief complaint
 Shortness of breath22 (61.1%)
 Altered mental status6 (16.7%)
 Fever4 (11.1%)
  Fall2 (5.5%)
  Weakness1 (2.8%)
  Anorexia1 (2.8%)
Presenting symptoms
 Dyspnea23 (63.9%)
 Altered mental status9 (25.0%)
 Fever15 (41.7%)
 Cough12 (33.3%)
 Fatigue7 (19.4%)
 Rhinorrhea2 (3.0%)
 GI symptoms3 (8.3%)
Comorbidities
 Hypertension28 (77.8%)
 Diabetes mellitus 219 (52.8%)
 Heart disease8 (22.2%)
 Stroke2 (5.6%)
 COPD3 (8.3%)
 Bronchial asthma3 (8.3%)
Maintenance medications for dementia
 Memantine16 (44.4%)
 Cholinesterase inhibitor13 (36.1%)
 Divalproex7 (19.4%)
Vital signs on admission, median (IQR)
 Temperature (Celsius)37.9 (37.2– 38.8)
 Respiratory rate22 (20– 26.8)
 MAP67.5 (59.8– 79)
 Heart rate108.5 (96.3– 120.3)S
 SpO2 on room air (%)86 (83– 94)
Highest oxygen support on admission
 Invasive mechanical ventilation4 (11.1%)
 Non-invasive mechanical ventilation0
 Non-rebreather mask15 (41.7%)
 Face mask1 (2.8%)
 High flow nasal cannula2 (5.6%)
 Nasal cannula11 (30.6%)
 Room air3 (8.3%)
Clinical outcomes
 Discharged to home/nursing home5 (13.9%)
 In-hospital mortality22 (61.1%)
 ICU admission8 (22.2%)
 Still admitted as of 04/21/20203 (8.3%)
 DNR or DNI status24 (66.7%)

aPatients with critical disease were those who developed acute respiratory distress syndrome, septic shock or multiorgan failure, or those who required mechanical ventilation or ICU admission. Patients were classified as having severe disease if their oxygen saturation was 93% and below when measured by pulse oximetry or if their respiratory rate was 30 breaths per min or higher without meeting any of the criteria for critical disease. Mild pneumonia was diagnosed in patients with an oxygen saturation on room air of 94% and above when measured by pulse oximetry and a respiratory frequency of less than 30 breaths per min without meeting any of the criteria for severe or critical disease.

DNR, do not resuscitate; DNI, do not intubate.

On admission, patients presented with a median mean arterial pressure (MAP) of 67.5 mmHg (59.8-79.0) and a median oxygen saturation on room air of 86% (83–94%). Advanced directives determined either by family decisions or long-term care facility documentation were noted in 24 (66.7%) patients. There were 22 (61.1%) deaths among the patients. We provide a detailed history of patients of older age with dementia who developed Covid-19. While in large cohorts, fever and cough are the most common presenting symptoms among Covid-19 patients [1], our findings show that dyspnea and altered mental status may manifest as the prominent symptoms of Covid-19 among patients of older age with dementia. Predisposition towards delirium may increase the risk of further cognitive impairment [4]. We noted a remarkable void in this population’s medical history. As the majority of this cohort was unable to provide their own history in the emergency department, it is possible that caretakers were not made aware of their patients’ subjective complaints at home. The large proportion of patients with an unknown duration of illness prior to presentation underscores the challenges in establishing the details of Covid-19 in this population. This unknown highlights the importance of including Covid-19 in the differential for patients with dementia presenting with a myriad of respiratory and non-respiratory symptoms. Notably, dyspnea and a remarkably low oxygen saturation and MAP on admission are suggestive of a pneumonia that lasted for several days [1]. Balancing aggressive management of an acute infection and the need for comfort care is crucial in this population. Thus, the interpretation of clinical outcomes, such as mortality and ICU admission, must be evaluated with caution. What is definite, however, is the unprecedented need to open discussions with families about the merits of either curative or palliative measures of care.
  3 in total

1.  Clinical phenotypes of delirium during critical illness and severity of subsequent long-term cognitive impairment: a prospective cohort study.

Authors:  Timothy D Girard; Jennifer L Thompson; Pratik P Pandharipande; Nathan E Brummel; James C Jackson; Mayur B Patel; Christopher G Hughes; Rameela Chandrasekhar; Brenda T Pun; Leanne M Boehm; Mark R Elstad; Richard B Goodman; Gordon R Bernard; Robert S Dittus; E W Ely
Journal:  Lancet Respir Med       Date:  2018-03       Impact factor: 30.700

2.  Prevalence of dementia in the United States: the aging, demographics, and memory study.

Authors:  B L Plassman; K M Langa; G G Fisher; S G Heeringa; D R Weir; M B Ofstedal; J R Burke; M D Hurd; G G Potter; W L Rodgers; D C Steffens; R J Willis; R B Wallace
Journal:  Neuroepidemiology       Date:  2007-10-29       Impact factor: 3.282

3.  Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study.

Authors:  Fei Zhou; Ting Yu; Ronghui Du; Guohui Fan; Ying Liu; Zhibo Liu; Jie Xiang; Yeming Wang; Bin Song; Xiaoying Gu; Lulu Guan; Yuan Wei; Hui Li; Xudong Wu; Jiuyang Xu; Shengjin Tu; Yi Zhang; Hua Chen; Bin Cao
Journal:  Lancet       Date:  2020-03-11       Impact factor: 79.321

  3 in total
  4 in total

1.  "A Different Way to Survive": The Experiences of Family Caregivers of Persons Living With Dementia During the COVID-19 Pandemic.

Authors:  Sara Masoud; Ashlie A Glassner; Mayra Mendoza; Shanae Rhodes; Carole L White
Journal:  J Fam Nurs       Date:  2022-07-08       Impact factor: 2.680

2.  Clinical course and risk factors of fatal adverse outcomes in COVID-19 patients in Korea: a nationwide retrospective cohort study.

Authors:  Juhyun Song; Dae Won Park; Jae-Hyung Cha; Hyeri Seok; Joo Yeong Kim; Jonghak Park; Hanjin Cho
Journal:  Sci Rep       Date:  2021-05-12       Impact factor: 4.379

3.  Covid-19: a call for mobilizing geriatric expertise.

Authors:  Shane O'Hanlon; Jugdeep Dhesi; Louise Aronson; Sharon K Inouye
Journal:  Eur Geriatr Med       Date:  2021-06       Impact factor: 1.710

4.  Authors' reply to: Comment to better understanding of the study "Clinical characteristics and prognostic factors in COVID-19 patients aged ≥80 years".

Authors:  Marcello Covino; Giuseppe De Matteis; Francesco Franceschi
Journal:  Geriatr Gerontol Int       Date:  2020-10-04       Impact factor: 2.730

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.